A Review of Clinical Pharmacokinetic and Pharmacodynamic Profiles of Select Antiretrovirals: Focus on Differences among Chinese Patients-Reference-Cited by-全球学者库

A Review of Clinical Pharmacokinetic and Pharmacodynamic Profiles of Select Antiretrovirals: Focus on Differences among Chinese Patients

Published:2019-11-15 Issue:12 Volume:39 Page:1179-1189
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Du Xiaoli¹,Peng Wenxiu¹^ORCID,Fu Qiang¹,Ma Qing²^ORCID,Zhu Zhu¹,Li Taisheng³

Affiliation:

1. Department of Pharmacy Peking Union Medical College Hospital Chinese Academy of Medical Sciences Beijing China

2. Translational Pharmacology Research Core NYS Center of Excellence in Bioinformatics and Life Sciences Buffalo New York

3. Department of Infectious Diseases AIDS Diagnosis and Treatment Center Peking Union Medical College Hospital Chinese Academy of Medical Sciences Beijing China

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2333

Reference88 articles.

1. Food and Drug Administration.Antiretroviral drugs used in the treatment of HIV infection.2018. Available fromhttps://www.fda.gov/patients/hiv-treatment/antiretroviral-drugs-used-treatment-hiv-infection. Accessed May 14 2018.

2. Changing patterns of mortality across Europe in patients infected with HIV-1

3. Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

4. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

5. World Health Organization.Update of recommendations on first‐ and second‐line antiretroviral regimens.2019. Available fromhttps://www.who.int/hiv/en/. Accessed September 7 2019.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study;Infectious Diseases and Therapy;2023-10-16

2. Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study;INFECT DIS THER;2023

3. Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea;Viruses;2022-11-18

4. Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function;Expert Review of Clinical Pharmacology;2022-05-04

5. Inter‐ethnic differences in pharmacokinetics—is there more that unites than divides?;Pharmacology Research & Perspectives;2021-11-02